Japan's patent linkage policy faces domestic debate and foreign pressure
Japan’s patent linkage system, which ties the regulatory approval of generic and biosimilar drugs to an evaluation of innovator patents, has come under renewed scrutiny amid legal challenges and growing calls...To view the full article, register now.
Already a subscriber? Click here to view full article